Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Milani

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 4, 2020
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatmentA Ianza, F Giudici, C Pinello, et al.
British Journal of Cancer|January 26, 2005
Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclinesA Berruti, R Bitossi, G Gorzegno, et al.
British Journal of Cancer|April 13, 2013
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancerG Allevi, C Strina, D Andreis, et al.
Arquivos Brasileiros De Cardiologia|November 13, 2014
South American guidelines for cardiovascular disease prevention and rehabilitationA H Herdy, F López-Jiménez, C P Terzic, et al.
Breast (Edinburgh, Scotland)|July 19, 2016
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancerD Andreis, S Bonardi, G Allevi, et al.
Breast (Edinburgh, Scotland)|May 4, 2019
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trialsS P Corona, G Roviello, C Strina, et al.
Nanotechnology|May 18, 2011
Up-regulation of T lymphocyte and antibody production by inflammatory cytokines released by macrophage exposure to multi-walled carbon nanotubesAna Carolina P Grecco, Rosemeire F O Paula, Erica Mizutani, et al.
British Journal of Cancer|December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancerL Bazzola, C Foroni, D Andreis, et al.
British Journal of Haematology|June 9, 2007
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomasM Ponzoni, F Berger, C Chassagne-Clement, et al.
Arquivos Brasileiros De Cardiologia|February 21, 2014
[I Brazilian Guidelines for cardiovascular prevention]A F Simão, D B Precoma, J P Andrade, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 4, 2020
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatmentA Ianza, F Giudici, C Pinello, et al.
British Journal of Cancer|January 26, 2005
Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclinesA Berruti, R Bitossi, G Gorzegno, et al.
British Journal of Cancer|April 13, 2013
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancerG Allevi, C Strina, D Andreis, et al.
Arquivos Brasileiros De Cardiologia|November 13, 2014
South American guidelines for cardiovascular disease prevention and rehabilitationA H Herdy, F López-Jiménez, C P Terzic, et al.
Breast (Edinburgh, Scotland)|July 19, 2016
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancerD Andreis, S Bonardi, G Allevi, et al.
Breast (Edinburgh, Scotland)|May 4, 2019
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trialsS P Corona, G Roviello, C Strina, et al.
Nanotechnology|May 18, 2011
Up-regulation of T lymphocyte and antibody production by inflammatory cytokines released by macrophage exposure to multi-walled carbon nanotubesAna Carolina P Grecco, Rosemeire F O Paula, Erica Mizutani, et al.
British Journal of Cancer|December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancerL Bazzola, C Foroni, D Andreis, et al.
British Journal of Haematology|June 9, 2007
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomasM Ponzoni, F Berger, C Chassagne-Clement, et al.
Arquivos Brasileiros De Cardiologia|February 21, 2014
[I Brazilian Guidelines for cardiovascular prevention]A F Simão, D B Precoma, J P Andrade, et al.
Pageof 24